• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有药物不依从性的两室药代动力学模型的统计分析。

Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence.

机构信息

School of Mathematics and Statistics, Shaanxi Normal University, Xi'an, 710119, People's Republic of China.

School of Science, Shanghai Maritime University, Shanghai, 201306, People's Republic of China.

出版信息

Bull Math Biol. 2023 Jun 9;85(7):65. doi: 10.1007/s11538-023-01173-0.

DOI:10.1007/s11538-023-01173-0
PMID:37294520
Abstract

Poor drug adherence is considered one of major barriers to achieving the clinical and public health benefits of many pharmacotherapies. In the current paper, we aim to investigate the impact of dose omission on the plasma concentrations of two-compartment pharmacokinetic models with two typical routes of drug administration, namely the intravenous bolus and extravascular first-order absorption. First, we reformulate the classical two-compartment pharmacokinetic models with a new stochastic feature, where a binomial random model of dose intake is integrated. Then, we formalize the explicit expressions of expectation and variance for trough concentrations and limit concentrations, with the latter proved of the existence and uniqueness for steady-state distribution. Moreover, we mathematically demonstrate the strict stationarity and ergodicity of trough concentrations as a Markov chain. In addition, we numerically simulate the impact of drug non-adherence to different extents on the variability and regularity of drug concentration and compare the drug pharmacokinetic preference between one and two compartment pharmacokinetic models. The results of sensitivity analysis also suggest the drug non-adherence as one of the most sensitive model parameters to the expectation of limit concentration. Our modelling and analytical approach can be integrated into the chronic disease models to estimate or quantitatively predict the therapy efficacy with drug pharmacokinetics presumably affected by random dose omissions.

摘要

药物依从性差被认为是许多药物治疗无法实现临床和公共卫生效益的主要障碍之一。在本文中,我们旨在研究剂量遗漏对两种典型给药途径(即静脉推注和血管外一级吸收)的两室药代动力学模型的血浆浓度的影响。首先,我们用新的随机特征重新构建经典的两室药代动力学模型,其中整合了一种二项式随机剂量摄入模型。然后,我们正式确定了谷底浓度和极限浓度的期望和方差的显式表达式,后者证明了稳态分布的存在性和唯一性。此外,我们从数学上证明了谷底浓度作为马尔可夫链的严格平稳性和遍历性。此外,我们还数值模拟了药物不依从性对药物浓度变异性和规律性的不同程度的影响,并比较了一室和两室药代动力学模型之间的药物药代动力学偏好。敏感性分析的结果还表明,药物不依从性是极限浓度期望值最敏感的模型参数之一。我们的建模和分析方法可以整合到慢性病模型中,以估计或定量预测药物治疗效果,因为药物药代动力学可能受到随机剂量遗漏的影响。

相似文献

1
Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence.具有药物不依从性的两室药代动力学模型的统计分析。
Bull Math Biol. 2023 Jun 9;85(7):65. doi: 10.1007/s11538-023-01173-0.
2
Statistical analysis of one-compartment pharmacokinetic models with drug adherence.具有药物依从性的一室药代动力学模型的统计分析
J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):209-225. doi: 10.1007/s10928-021-09794-5. Epub 2021 Oct 27.
3
An Analytical Approach of One-Compartmental Pharmacokinetic Models with Sigmoidal Hill Elimination.具有 sigmoidal Hill 消除的单室药代动力学模型的分析方法。
Bull Math Biol. 2022 Sep 13;84(10):117. doi: 10.1007/s11538-022-01078-4.
4
Analytical Solution and Exposure Analysis of a Pharmacokinetic Model with Simultaneous Elimination Pathways and Endogenous Production: The Case of Multiple Dosing Administration.具有同时消除途径和内源性产生的药代动力学模型的分析解和暴露分析:多次给药的情况。
Bull Math Biol. 2019 Sep;81(9):3436-3459. doi: 10.1007/s11538-019-00651-8. Epub 2019 Aug 16.
5
A technical note concerning non-adherence to drug therapy: exact expressions for the mean and variance of drug concentration.关于药物治疗不依从性的技术说明:药物浓度均值和方差的精确表达式
Health Care Manag Sci. 2008 Sep;11(3):296-301. doi: 10.1007/s10729-007-9046-3.
6
Designing Drug Regimens that Mitigate Nonadherence.设计减轻不依从性的药物治疗方案。
Bull Math Biol. 2021 Dec 20;84(1):20. doi: 10.1007/s11538-021-00976-3.
7
ADVAN-style analytical solutions for common pharmacokinetic models.常见药代动力学模型的ADVAN式解析解。
J Pharmacol Toxicol Methods. 2015 May-Jun;73:42-8. doi: 10.1016/j.vascn.2015.03.004. Epub 2015 Apr 2.
8
A pharmacokinetic formalism explicitly integrating the patient drug compliance.一种明确整合患者药物依从性的药代动力学形式。
J Pharmacokinet Pharmacodyn. 2007 Feb;34(1):115-39. doi: 10.1007/s10928-006-9036-y. Epub 2006 Oct 12.
9
Variability and singularity arising from poor compliance in a pharmacokinetic model I: the multi-IV case.源于药代动力学模型中较差依从性的可变性和奇点 I:多 IV 情况。
J Pharmacokinet Pharmacodyn. 2013 Feb;40(1):15-39. doi: 10.1007/s10928-012-9284-y. Epub 2012 Dec 30.
10
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.多柔比星的群体药代动力学:成人和 3 岁以上儿童 NONMEM 模型的建立。
Cancer Chemother Pharmacol. 2013 Mar;71(3):749-63. doi: 10.1007/s00280-013-2069-1. Epub 2013 Jan 13.

引用本文的文献

1
The Morisky Method for Measuring Medication Adherence in Older Adults With Chronic Diseases: A Cross-Sectional Study.用于测量老年慢性病患者药物依从性的Morisky方法:一项横断面研究。
Health Sci Rep. 2025 Apr 28;8(5):e70681. doi: 10.1002/hsr2.70681. eCollection 2025 May.
2
Fluconazole Dosing for the Prevention of spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations.氟康唑用于预防血液肿瘤儿科患者 属感染的给药:群体药代动力学建模与目标达成概率模拟
Pharmaceutics. 2025 Apr 8;17(4):488. doi: 10.3390/pharmaceutics17040488.